التفاصيل البيبلوغرافية
| العنوان: |
Antiretroviral therapy options in people living with HIV at risk of or with osteoporosis: Comment on "Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis". |
| المؤلفون: |
Noe, S.1 sno@jajaprax.de, Jaeger, H.1, Wolf, E.2 |
| المصدر: |
Osteoporosis International. Aug2019, Vol. 30 Issue 8, p1705-1706. 2p. |
| مصطلحات موضوعية: |
*OSTEOPOROSIS prevention, *OSTEOPOROSIS treatment, *ANTIRETROVIRAL agents, *TENOFOVIR, *BONE resorption, *BONE fractures, *HIV-positive persons, *DISEASE risk factors, *THERAPEUTICS |
| مستخلص: |
The authors discuss a position statement of the Swiss Association against Osteoporosis on diagnosis, prevention, and treatment of bone fragility in people with human immunodeficiency virus (HIV). Topics mentioned include options to avoid tenofovir disoproxil fumarate (TDF)-containing antiretroviral therapy (ART), the choice of alternative ART regimen, and a tenofovir alafenamide equivalent as an alternative to TDF. |
| قاعدة البيانات: |
Academic Search Index |
